Emergency management of patients being treated with oral anticoagulants
AbstractVitamin K antagonists (VKA) are among the most widely prescribed drugs in the industrialized world. In fact, for decades, VKA have been the only orally available anticoagulant for the primary and secondary prevention of venous and arterial thrombotic events. Their efficacy has been widely demonstrated in a series of studies carried out in the 1990s. Since the incidences of atrial fibrillation and venous thromboembolism increase exponentially with age, the number of anticoagulated patients is destined to increase. This paper examines anticoagulation therapy management with particular attention to the use of VKA.
- Abstract views: 794
- PDF: 617
- HTML: 298
Copyright (c) 2013 Franco Manzato, Massimo Franchini
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.